ContraFect Corp Company Profile (NASDAQ:CFRX)

About ContraFect Corp

ContraFect Corp logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CFRX
  • CUSIP:
Key Metrics:
  • Previous Close: $2.15
  • 50 Day Moving Average: $1.84
  • 200 Day Moving Average: $2.17
  • 52-Week Range: $1.35 - $4.12
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.59
  • P/E Growth: 0.00
  • Market Cap: $89.39M
  • Outstanding Shares: 41,578,000
  • Beta: -1.09
Profitability:
  • Return on Equity: -171.11%
  • Return on Assets: -110.46%
Debt:
  • Current Ratio: 6.91%
  • Quick Ratio: 6.91%
Additional Links:
Companies Related to ContraFect Corp:

Analyst Ratings

Consensus Ratings for ContraFect Corp (NASDAQ:CFRX) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.10 (137.21% upside)

Analysts' Ratings History for ContraFect Corp (NASDAQ:CFRX)
Show:
DateFirmActionRatingPrice TargetDetails
11/21/2016Piper Jaffray CompaniesSet Price TargetBuy$5.00View Rating Details
9/28/2016William BlairInitiated CoverageOutperformView Rating Details
8/9/2016Maxim GroupReiterated RatingHoldView Rating Details
5/10/2016Roth CapitalDowngradeBuy -> Neutral$4.00 -> $3.30View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for ContraFect Corp (NASDAQ:CFRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
8/9/2016Q216($0.27)($0.35)ViewN/AView Earnings Details
5/10/2016($0.25)($0.32)ViewN/AView Earnings Details
3/15/2016Q415($0.23)($0.28)ViewN/AView Earnings Details
8/13/2015($0.27)($0.33)ViewN/AView Earnings Details
5/15/2015($0.23)($0.24)ViewN/AView Earnings Details
4/7/2015($0.23)($0.23)ViewN/AView Earnings Details
11/14/2014($0.15)($1.22)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ContraFect Corp (NASDAQ:CFRX)
Current Year EPS Consensus Estimate: $-1.14 EPS
Next Year EPS Consensus Estimate: $-0.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.23)($0.25)
Q2 20162($0.25)($0.23)($0.24)
Q3 20163($0.28)($0.18)($0.23)
Q4 20163($0.27)($0.24)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ContraFect Corp (NASDAQ:CFRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ContraFect Corp (NASDAQ:CFRX)
Insider Ownership Percentage: 15.00%
Institutional Ownership Percentage: 46.18%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2016Steven C GilmanCEOBuy20,000$2.48$49,600.00View SEC Filing  
11/17/2015Daniel CoutoSVPSell2,872$3.81$10,942.32View SEC Filing  
11/3/2015Daniel CoutoSVPSell2,867$4.23$12,127.41View SEC Filing  
10/20/2015Daniel CoutoSVPSell2,867$4.48$12,844.16View SEC Filing  
10/6/2015Daniel CoutoSVPSell2,867$4.11$11,783.37View SEC Filing  
9/22/2015Daniel CoutoSVPSell2,867$4.76$13,646.92View SEC Filing  
9/8/2015Daniel CoutoSVPSell2,867$4.90$14,048.30View SEC Filing  
3/2/2015Julia P GregoryCEOBuy11,778$4.61$54,296.58View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ContraFect Corp (NASDAQ:CFRX)
DateHeadline
4-traders.com logoContraFect : Lisa Ricciardi to Join Board of Directors (NASDAQ:CFRX)
www.4-traders.com - February 16 at 9:21 PM
us.rd.yahoo.com logoLisa Ricciardi to Join Board of Directors (NASDAQ:CFRX)
us.rd.yahoo.com - February 16 at 9:40 AM
finance.yahoo.com logoCONTRAFECT CORP Financials (NASDAQ:CFRX)
finance.yahoo.com - February 8 at 4:33 PM
News IconContraFect Corp CFRX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CFRX)
www.bioportfolio.com - January 26 at 5:07 PM
us.rd.yahoo.com logo7:02 am ContraFect reports investigational drug product lot did not meet manufacturing release specifications; now expects to initiate the Phase 2 study of CF-301 in Staph aureus in mid-2017 (NASDAQ:CFRX)
us.rd.yahoo.com - January 6 at 4:39 PM
publicnow.com logoContraFect Provides Program Update (NASDAQ:CFRX)
www.publicnow.com - January 6 at 4:39 PM
finance.yahoo.com logoContraFect to Present at Biotech Showcase 2017 Conference (NASDAQ:CFRX)
finance.yahoo.com - January 4 at 5:19 PM
live-pr.com logoNew Market Research Report: ContraFect Corporation (CFRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (NASDAQ:CFRX)
www.live-pr.com - December 24 at 2:29 AM
insidermonkey.com logoIs ContraFect Corp (CFRX) A Good Stock To Buy? (NASDAQ:CFRX)
www.insidermonkey.com - December 11 at 4:01 PM
capitalcube.com logoContraFect Corp. :CFRX-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 (NASDAQ:CFRX)
www.capitalcube.com - December 1 at 4:21 PM
finance.yahoo.com logoGreenwood Hall Announces Appointment of Rubinstein, Sucoff, and Poutre to Board of Directors (NASDAQ:CFRX)
finance.yahoo.com - November 30 at 8:00 AM
4-traders.com logoContraFect : to Present at 28th Annual Piper Jaffray Healthcare Conference (NASDAQ:CFRX)
www.4-traders.com - November 24 at 12:04 PM
finance.yahoo.com logoContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference (NASDAQ:CFRX)
finance.yahoo.com - November 23 at 1:10 PM
marketwired.com logoContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301 (NASDAQ:CFRX)
www.marketwired.com - November 17 at 3:24 PM
streetinsider.com logoContraFect (CFRX) Receives $2.1M PRMRP-Related Development Award (NASDAQ:CFRX)
www.streetinsider.com - November 17 at 3:24 PM
News IconContraFect Corporation CFRX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CFRX)
www.bioportfolio.com - November 16 at 9:52 PM
einnews.com logoContraFect Announces Expanded Research Collaboration with The Rockefeller University to Identify Lysin Therapeutics Targeting Gram-negative Bacteria (NASDAQ:CFRX)
uspolitics.einnews.com - November 14 at 9:43 PM
finance.yahoo.com logoCFRX: Preparations Continue for Launch of Phase 2 Clinical Trial of CF-301 in 4Q16… (NASDAQ:CFRX)
finance.yahoo.com - November 14 at 4:20 PM
marketexclusive.com logoContraFect Corporation (NASDAQ:CFRX) (NASDAQ:CFRXW) Files An 8-K Reports Third Quarter 2016 Financial Results and Provides Business Update (NASDAQ:CFRX)
marketexclusive.com - November 10 at 10:12 PM
finance.yahoo.com logoContraFect to Present at The Lysin Meeting (NASDAQ:CFRX)
finance.yahoo.com - November 10 at 10:12 PM
News IconContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update (NASDAQ:CFRX)
www.andhranews.net - November 9 at 10:38 PM
marketwired.com logoContraFect Announces Organizational Changes (NASDAQ:CFRX)
www.marketwired.com - September 17 at 8:57 AM
finance.yahoo.com logoCFRX: CF-301 Phase 2 Study in Bacteremia to Initiate in 4Q16 (NASDAQ:CFRX)
finance.yahoo.com - August 11 at 4:16 PM
marketwired.com logoContraFect Announces Second Quarter 2016 Results (NASDAQ:CFRX)
www.marketwired.com - August 9 at 12:01 PM
sg.finance.yahoo.com logoContraFect reports 2Q loss (NASDAQ:CFRX)
sg.finance.yahoo.com - August 9 at 12:01 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:CFRX)
biz.yahoo.com - August 9 at 12:01 PM
publicnow.com logoContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency (NASDAQ:CFRX)
www.publicnow.com - August 4 at 12:37 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements an (NASDAQ:CFRX)
biz.yahoo.com - July 27 at 9:31 AM
streetinsider.com logoContraFect (CFRX) Prices 14M Common Stock, Warrants Offering for Proceeds of ~$35M (NASDAQ:CFRX)
www.streetinsider.com - July 22 at 4:12 PM
hotstocked.com logoContraFect Corp (NASDAQ:CFRX) Loses Ground On New Stock Offering (NASDAQ:CFRX)
www.hotstocked.com - July 22 at 4:12 PM
finance.yahoo.com logoCFRX: Company Raises $35 Million; Steven Gilman Appointed as CEO (NASDAQ:CFRX)
finance.yahoo.com - July 22 at 2:20 PM
finance.yahoo.com logoContraFect downgraded by Maxim Group (NASDAQ:CFRX)
finance.yahoo.com - July 22 at 11:51 AM
publicnow.com logoContraFect Corporation Prices $35 Million Public Offering of Common Stock and Warrants (NASDAQ:CFRX)
www.publicnow.com - July 22 at 10:18 AM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal (NASDAQ:CFRX)
biz.yahoo.com - July 21 at 5:30 PM
finance.yahoo.com logoContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer (NASDAQ:CFRX)
finance.yahoo.com - July 21 at 5:29 PM
finance.yahoo.com logoCFRX: New PK/PD and Microbiologic Data Presented on CF-301 (NASDAQ:CFRX)
finance.yahoo.com - June 27 at 2:30 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CFRX)
biz.yahoo.com - June 27 at 6:10 AM
publicnow.com logoContraFect Presents New CF-301 Data at ASM Microbe 2016 (NASDAQ:CFRX)
www.publicnow.com - June 21 at 7:29 AM
finance.yahoo.com logo7:01 am ContraFect announces 3 presentations of new data on CF-301 at ASM 2016 (NASDAQ:CFRX)
finance.yahoo.com - June 21 at 7:01 AM
capitalcube.com logoContraFect Corp. :CFRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 (NASDAQ:CFRX)
www.capitalcube.com - June 10 at 5:04 PM
publicnow.com logoContraFect Announces Presentation of Data at ASM Microbe 2016 (NASDAQ:CFRX)
www.publicnow.com - June 8 at 7:08 AM
publicnow.com logoContraFect to Present at Jefferies 2016 Healthcare Conference (NASDAQ:CFRX)
www.publicnow.com - June 1 at 7:23 AM
publicnow.com logoContraFect Announces First Quarter 2016 Results (NASDAQ:CFRX)
www.publicnow.com - May 10 at 7:28 AM
biz.yahoo.com logoQ1 2016 ContraFect Corp Earnings Release - Time Not Supplied (NASDAQ:CFRX)
biz.yahoo.com - May 10 at 7:07 AM
publicnow.com logoContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016 (NASDAQ:CFRX)
www.publicnow.com - May 3 at 7:10 AM
finance.yahoo.com logoCFRX: CF-301 Phase 1 Results Presented at ECCMID Conference (NASDAQ:CFRX)
finance.yahoo.com - April 12 at 1:35 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CFRX)
biz.yahoo.com - April 12 at 6:03 AM
publicnow.com logoKeryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors (NASDAQ:CFRX)
www.publicnow.com - April 1 at 8:46 AM
publicnow.com logoKeryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors (NASDAQ:CFRX)
www.publicnow.com - April 1 at 8:46 AM
publicnow.com logoContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference (NASDAQ:CFRX)
www.publicnow.com - March 29 at 7:24 AM

Social

What is ContraFect Corp's stock symbol?

ContraFect Corp trades on the NASDAQ under the ticker symbol "CFRX."

Where is ContraFect Corp's stock going? Where will ContraFect Corp's stock price be in 2017?

4 analysts have issued 1-year price targets for ContraFect Corp's stock. Their predictions range from $3.30 to $7.00. On average, they anticipate ContraFect Corp's stock price to reach $5.10 in the next twelve months.

When will ContraFect Corp announce their earnings?

ContraFect Corp is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

Who owns ContraFect Corp stock?

ContraFect Corp's stock is owned by a number of of institutional and retail investors. Top institutional investors include Federated Investors Inc. PA (4.81%), Broadfin Capital LLC (3.44%), Birchview Capital LP (1.74%) and Sunbelt Securities Inc. (0.48%). Company insiders that own ContraFect Corp stock include Daniel Couto, Julia P Gregory and Steven C Gilman.

How do I buy ContraFect Corp stock?

Shares of ContraFect Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of ContraFect Corp stock cost?

One share of ContraFect Corp stock can currently be purchased for approximately $2.15.

ContraFect Corp (NASDAQ:CFRX) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for ContraFect Corp (NASDAQ:CFRX)

Earnings History Chart

Earnings by Quarter for ContraFect Corp (NASDAQ:CFRX)

Dividend History Chart

Dividend Payments by Quarter for ContraFect Corp (NASDAQ:CFRX)

Last Updated on 2/21/2017 by MarketBeat.com Staff